Australia's most trusted source of pharma news
Tuesday, 07 April 2020
Lost Your Access?
CSL leads global COVID alliance
In TGA talks to develop, trial potential new medicine.
'Stay home' plead lung patients
Easter message with a difference from the Lung Foundation.
COVID could blind fearful
Aussies skipping eye shots face dim future say docs.
Hunt's ministry scaled back
Temporarily loses APSC to concentrate on Health.
CROs look to virtual trials
Embrace technology to monitor patients in COVID.
PBAC handles ad hoc requests
Managing COVID issues prior to next intracycle meet.
AbbVie drops patent for COVID
Allows Mylan copy of Kaletra in for local trials.
Roche NZ boss returns to Aust
Pharma veteran takes up new leadership role.
Pharma unites in Oz COVID fight
ACCC allows 48 companies to combine meds supply effort.
MSD, Pfizer staff join frontlines
Companies offer Aussie COVID volunteers full pay.
Jobs go at BMS' Celgene
ANZ boss among leaders let go since acquisition.
Novartis, Amgen in COVID race
Jakavi latest candidate to enter trials.
Hunt gives vax tester $220m
CSIRO animal lab gets funding boost and new name.
Aust M&A deals face scrutiny
FIRB tipped to focus on foreign healthcare buys.
HCP COVID stress runs high
Stress, workloads up for HCPs since outbreak.
COVID trials pop up in Aust
Local trial tracker shows what's being tested and where.
Two targeted cancer drugs arrive
Latest from Astellas, Emerge approved by TGA.
Pharma speaks out on HCPs
What you said about rep interactions during COVID-19.
Top of the Hill
Reps face virtual dilemma
Is Zoom-meeting doctors a no or go in COVID-19?
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design